Summer activity #1
Vaccines Focus (1/2)

Accelerated vaccines development and production: in-process NGS QC testing for risk mitigations 

The impact of COVID-19 has highlighted the biopharmaceutical industry’s need for fast & innovative solutions to accelerate the development and production of vaccines.

Next-generation sequencing (NGS)  is a performant, validated, and secure method that brings significant advantages in terms of turnaround time, safety, and cost-effectiveness to the vaccine production process.

This 25 min long webinar reviews QC tools to mitigate risks and comparison of NGS with other available methods.